Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedNov 23, 2025
DataAggregated Company Financials
Companies21
  • 7D-1.6%
  • 3M-11.6%
  • 1Y-52.4%
  • YTD-45.0%

Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by Novo Nordisk declining 2.1%. Overall the industry is down 52% in 12 months. Earnings are forecast to grow by 5.2% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 23 Nov 2025DKK 1.9tDKK 454.3bDKK 137.1b17.1x13.5x4.1x
Tue, 21 Oct 2025DKK 2.1tDKK 447.6bDKK 141.7b19.1x14.9x4.7x
Thu, 18 Sep 2025DKK 2.1tDKK 447.1bDKK 141.6b18.9x15x4.8x
Sat, 16 Aug 2025DKK 1.9tDKK 444.4bDKK 140.3b28.1x13.6x4.3x
Mon, 14 Jul 2025DKK 2.4tDKK 423.1bDKK 124.5b29.9x19.3x5.7x
Wed, 11 Jun 2025DKK 2.8tDKK 423.7bDKK 124.7b31.2x22.4x6.6x
Fri, 09 May 2025DKK 2.3tDKK 422.8bDKK 124.7b21.4x18.8x5.5x
Sun, 06 Apr 2025DKK 2.4tDKK 409.5bDKK 121.3b22.8x19.4x5.8x
Tue, 04 Mar 2025DKK 3.4tDKK 410.0bDKK 121.4b28x27.8x8.2x
Thu, 30 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b28.9x29.2x8.4x
Sat, 28 Dec 2024DKK 3.4tDKK 387.4bDKK 111.3b29.9x30.1x8.7x
Mon, 25 Nov 2024DKK 3.9tDKK 387.4bDKK 111.3b31x34.9x10x
Wed, 23 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b35.4x38.6x11.1x
Fri, 20 Sep 2024DKK 4.6tDKK 371.9bDKK 107.1b36.7x42.9x12.4x
Sun, 18 Aug 2024DKK 4.7tDKK 370.7bDKK 107.0b37.2x43.9x12.7x
Tue, 16 Jul 2024DKK 4.9tDKK 355.2bDKK 106.2b35.5x46.2x13.8x
Thu, 13 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b36.4x46.3x13.9x
Sat, 11 May 2024DKK 4.5tDKK 354.9bDKK 106.0b34.6x42.5x12.7x
Mon, 08 Apr 2024DKK 4.5tDKK 341.2bDKK 99.6b37.4x44.7x13x
Wed, 06 Mar 2024DKK 4.4tDKK 340.0bDKK 98.9b38.2x44.6x13x
Fri, 02 Feb 2024DKK 4.0tDKK 320.8bDKK 90.1b32x44.7x12.6x
Sun, 31 Dec 2023DKK 3.6tDKK 320.4bDKK 90.0b32.8x40.4x11.3x
Tue, 28 Nov 2023DKK 3.7tDKK 320.5bDKK 90.0b33.2x40.9x11.5x
Thu, 26 Oct 2023DKK 3.6tDKK 305.6bDKK 82.3b26.6x43.4x11.7x
Sat, 23 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b33.8x41.3x11.1x
Mon, 21 Aug 2023DKK 3.3tDKK 303.2bDKK 81.2b36.8x40.8x10.9x
Wed, 19 Jul 2023DKK 2.9tDKK 286.9bDKK 75.4b39x38.7x10.2x
Fri, 16 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40.5x40.2x10.6x
Sun, 14 May 2023DKK 3.2tDKK 284.8bDKK 74.9b41.2x43.1x11.3x
Tue, 11 Apr 2023DKK 3.0tDKK 272.4bDKK 68.5b39.4x43.5x10.9x
Thu, 09 Mar 2023DKK 2.8tDKK 292.6bDKK 69.2b38.7x40.1x9.5x
Sat, 04 Feb 2023DKK 2.7tDKK 285.8bDKK 69.0b38.1x38.9x9.4x
Mon, 02 Jan 2023DKK 2.7tDKK 276.0bDKK 66.3b36.7x40.3x9.7x
Wed, 30 Nov 2022DKK 2.6tDKK 276.2bDKK 66.3b37.6x38.8x9.3x
Price to Earnings Ratio

38.8x


Total Market Cap: DKK 2.6tTotal Earnings: DKK 66.3bTotal Revenue: DKK 276.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 35x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.7x which is lower than its 3-year average PE of 35.0x.
  • The 3-year average PS ratio of 9.7x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 27% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-1.38%
Healthcare-1.62%
Healthcare Services2.00%
Biotech1.18%
Life Sciences-0.83%
Medical Equipment-0.91%
Healthtech-2.03%
Pharma-2.06%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 25.2x.
    • Analysts are expecting annual earnings growth of 81.0%, which is higher than its past year's earnings decline of 99.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 94% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 15% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.97k0.7%
+DKK 892.7m		32.7%PE11.8x
AMBU B AmbuDKK 87.953.0%
+DKK 679.7m		-22.8%PE38.5x
BAVA Bavarian NordicDKK 184.004.3%
+DKK 594.9m		-7.3%PE5.9x
ZEAL Zealand PharmaDKK 521.801.6%
+DKK 576.4m		-28.2%PE5.6x
GUBRA GubraDKK 453.001.1%
+DKK 81.7m		-29.7%PE4.2x

Latest News

HLUN B
DKK 44.18
H. Lundbeck
7D
-2.9%
1Y
-2.4%

The Strong Earnings Posted By H. Lundbeck (CPH:HLUN B) Are A Good Indication Of The Strength Of The Business

Nov 22
The Strong Earnings Posted By H. Lundbeck (CPH:HLUN B) Are A Good Indication Of The Strength Of The Business
SMSMED
DKK 4.08
Scandinavian Medical Solutions
7D
2.0%
1Y
-38.6%
BIOPOR
DKK 1.03
BioPorto
7D
-9.6%
1Y
-36.6%
AMBU B
DKK 87.95
Ambu
7D
3.0%
1Y
-22.8%

AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum

Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.
ALK B
DKK 227.40
ALK-Abelló
7D
-1.2%
1Y
43.5%

ALK B: Improved Margins and China Partnership Will Drive Steady Outlook

Analysts have raised their price target for ALK-Abelló to DKK 219.33 from DKK 196.00. They cite ongoing improvements in profit margins and a slightly higher projected fair value as the reasons for the adjustment.
EMBLA
DKK 33.80
Embla Medical hf
7D
-0.9%
1Y
-5.8%

EMBLA: Share Buyback And Kyiv Clinic Launch Will Support Bullish Outlook

Analysts have maintained their target price for Embla Medical hf. at €37.40, citing minor adjustments to discount rates and future market assumptions, but no significant change in company fundamentals.
COLO B
DKK 580.20
Coloplast
7D
-1.5%
1Y
-34.9%

Coloplast (CPH:COLO B) Will Pay A Larger Dividend Than Last Year At DKK18.00

Nov 20
Coloplast (CPH:COLO B) Will Pay A Larger Dividend Than Last Year At DKK18.00
GMAB
DKK 1,968.00
Genmab
7D
0.7%
1Y
32.7%
VIRO
DKK 15.20
ViroGates
7D
17.4%
1Y
-1.3%
ZEAL
DKK 521.80
Zealand Pharma
7D
1.6%
1Y
-28.2%

Zealand Pharma A/S (CPH:ZEAL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 16
Zealand Pharma A/S (CPH:ZEAL) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
NOVO B
DKK 304.65
Novo Nordisk
7D
-2.1%
1Y
-59.4%
BAVA
DKK 184.00
Bavarian Nordic
7D
4.3%
1Y
-7.3%
DEMANT
DKK 214.80
Demant
7D
-1.2%
1Y
-19.3%

DEMANT: Improved Revenue Outlook Will Drive Earnings Growth Into 2025

Analysts have lowered their price target for Demant from DKK 284.19 to DKK 277.69. This change is due to a slight increase in the discount rate and marginal declines in profit margin projections, partially offset by improved revenue growth expectations.
GUBRA
DKK 453.00
Gubra
7D
1.1%
1Y
-29.7%
CHEMM
DKK 751.50
ChemoMetec
7D
-1.9%
1Y
59.1%
BRAINP
DKK 0.012
Brain+
7D
9.4%
1Y
-88.3%